BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Neocentromeres, Acetaminophen, rs2476601, PBX1, Metabolism of xenobiotics, Liver)
Bookmark Forward

QuickView for transmembrane receptor protein tyrosine kinase activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Tongue superior part with papillae
  2. Tonsil
  3. Bone marrow
  4. T Lymphocyte (CD4+) of peripheral blood
  5. Ileum mucosa
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Poisoning by drug AND/OR medicinal substance
  2. Severe acute respiratory syndrome
  3. Disease due to Orthopoxvirus
  4. Viral disease
  5. Retinal detachment
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. VX
  2. Nitrazepam
  3. Asbestos
  4. Ethylene Oxide
  5. Cytokines
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MTF2
  2. PDE6B
  3. LCP2
  4. NR5A1
  5. ANKRD2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. The Immunological Genome Project - Immune cell lineage differentiation and maturation
  2. Neural stem cell derived medulloblastoma tumors
  3. Ectoderm and mesenchyme gene expression at E10.5, E11.5 and E12.5
  4. Colorectal cancer cell sub-populations and TGF-beta-treated colon mucosa CCD-Co-18 cells
  5. Fractionated RNA in MCF-7 breast cancer cells
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and i…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. The Effect of the Preoperative Oral Carbohydrate Attenuating Immediate Postoperative Insulin Resista…
  2. Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
  3. Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Pati…
  4. Neoadjuvant GW572016 to Treat Breast Cancer
  5. ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Lin…
Explore Clinical Trials Results
  • Copyright © 2017 Illumina Inc. All rights reserved.